Oxford Asset Management’s Fibrocell Science Inc. FCSC Stock Holding History

Oxford Asset Management’s Portfolio FCSC Stock Details FCSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-91,533	Closed	-$137K	–	2173
2018 Q4	$137K	Buy	91,533 +79,862	+684%	+$160K	﹤0.01%	1614
2018 Q3	$28K	Buy	+11,671	New	+$25.2K	﹤0.01%	1662
2016 Q4	–	Sell	-9,668	Closed	-$104K	–	922
2016 Q3	$104K	Sell	9,668 -11,263	-54%	-$167K	﹤0.01%	738
2016 Q2	$361K	Buy	20,931 +7,868	+60%	+$245K	0.01%	630
2016 Q1	$490K	Buy	13,063 +10,531	+416%	+$420K	0.01%	615
2015 Q4	$174K	Buy	+2,532	New	+$182K	﹤0.01%	808

Other funds holding FCSC

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

ACA

Apis Capital Advisors New York $648M AUM 302.67% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Oxford Asset Management's FCSC Position: Q1 2019 in Review

Oxford Asset Management sold out of Fibrocell Science Inc. (FCSC) in Q1 2019, closing a stake of 91,533 shares — an estimated $137K sold.

Oxford Asset Management first reported a position in FCSC in Q4 2015 and held it in 6 quarters. The position peaked at $490K in Q1 2016. 23 funds tracked by Wall St. Rank hold FCSC as of Q1 2019.

Oxford Asset Management reported no remaining Fibrocell Science Inc. position as of Q1 2019 after selling out during the quarter.
Oxford Asset Management sold 91,533 Fibrocell Science Inc. shares in Q1 2019, an estimated $137K.
Oxford Asset Management first reported a position in Fibrocell Science Inc. in Q4 2015 and held it in 6 quarters.
Oxford Asset Management's Fibrocell Science Inc. position peaked at $490K in Q1 2016.
23 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q1 2019.

Based on Oxford Asset Management's 13F filing for Q1 2019, filed 15 May 2019.